$700,000,000 Settlement Involving PCBs

posted on:
January 11, 2008

author:
Staff

category:
Environmental | Landmark Verdict

August, 2003 – Environmental and legal experts from around the country are characterizing the $700 Million global settlement of the PCB damage claims of over 20,000 current and former residents of Calhoun County, Alabama as the most significant settlement of toxic tort damage claims in American history. Three months of settlement talks spearheaded by Beasley Allen and the Cochran Firm in their 17,000 plaintiff Federal court case, eventually led to a global resolution of not only that case, but also the long-running state court trial in Gadsden, Alabama that involved more than 3,000 additional plaintiffs.

Free Legal Consultation
At Beasley Allen, there is never a fee for legal services, unless we collect for you. Contact us today by filling out a brief questionnaire, or by calling our toll free number, 1-800-898-2034, for a free, no-cost no-obligation evaluation of your case.

VW agrees to settle emissions cheat litigation for more than $14 billion

posted on:
June 28, 2016

author:
Staff

category:
Fraud

A settlement reached June 27 between Volkswagen and owners of about half a million diesel-powered VW vehicles over the German automaker’s emissions cheat is worth more than $14 billion, including $10.033 billion set aside to cover vehicle buybacks and fixes, $2 billion for “green energy” funds and $2.7 billion to offset diesel emissions. The settlement is pending approval of U.S. District Judge Charles Breyer, who is overseeing the consolidated litigation.

Beasley Allen is one of the law firms chosen to litigate the Volkswagen case on behalf of plaintiffs harmed by the automaker’s emissions cheat. Beasley Allen Principal W. Daniel “Dee” Miles, III, who heads the firm’s Consumer Fraud section, was one of the 22 attorneys appointed by Judge Breyer to the Plaintiffs Steering Committee.

The settlement will compensate owners of some 482,000 model-year 2009-2015 VW and Audi vehicles with two-liter diesel engines. Under the agreement, vehicle owners would be allowed to choose whether to sell their vehicle back to VW or have it repaired. According to the terms of the settlement agreement, cash compensation offered to each car owner could range between $5,100 and $10,000 and total compensation will depend on the cars’ value before Volkswagen admitted to the emissions cheat.

Volkswagen installed the emissions cheat on 10.5 million diesel-powered vehicles worldwide, including the half million U.S. vehicles — all while promoting “clean diesel” as an alternative to electric and hybrid vehicles. The defeat device enables the vehicles to detect the special parameters of an emissions drive cycle, which prompts the vehicle’s computer to turn on emissions controls, thereby making the vehicle fully compliant with EPA rules during testing.

The software also senses steering, throttle, and other variables unique to real-time driving, which cues the computer to turn off emissions controls, allowing the vehicle to release extremely high levels of nitrogen-oxide emissions. These toxic emissions are up to 40 times higher than federal limits allow.

Free Legal Consultation
At Beasley Allen, there is never a fee for legal services, unless we collect for you. Contact us today by filling out a brief questionnaire, or by calling our toll free number, 1-800-898-2034, for a free, no-cost no-obligation evaluation of your case.

Cole Portis installed as 141st President of Alabama State Bar

posted on:
June 27, 2016

author:
Staff

category:
Community

The Alabama State Bar on Saturday, June 25, 2016, swore in Montgomery attorney J. Cole Portis of the Beasley Allen Law Firm as the 141st president of the 17,900-member organization.

“I am blessed to have the opportunity to lead our state bar, which has been entrusted with the obligation to serve our profession, seek improvements in our judicial system and serve the public,” said Alabama State Bar President J. Cole Portis of the Beasley Allen Law Firm. “We are committed to a new era of engagement with lawyers to ensure that they have resources available to help them in their practice. We are also committed to standing alongside our courts to ensure that the rule of law is enforced and dedicated to serving the public through pro bono work, charitable stewardship and involvement in everyday affairs that impact the communities where we practice law.”

Portis has served on multiple committees and task forces within the Alabama State Bar including the Finance and Audit Committee, Client Security Fund Committee and various others. He has also served on the Alabama State Bar Board of Bar Commissioners for the 15th judicial circuit since 2007.

Portis received his J.D. from The University of Alabama School of Law in 1990 and joined the Beasley Allen Law Firm in 1991, where he is now a principal. Portis represents people and families who are injured or killed by defective products. In addition to handling litigation matters at Beasley Allen, he manages the firm’s product liability/personal injury section.

He is a board member of the Alabama Law Foundation where he is also a fellow and a member of the Atticus Finch Society. He supports the Alabama Civil Justice Foundation through its Pioneers of Justice Society and is a Montgomery County Bar Association volunteer lawyer. He is past president of the Alabama State Bar Young Lawyers’ Section, the Montgomery County Bar Association and the Montgomery County Trial Lawyers Association.

Portis was recognized as a finalist for Public Justice’s 2014 Trial Lawyer of the Year. He is also an AV-rated lawyer by Martindale-Hubbell.

Above all, Portis is a husband and a father to nine children. He is married to Joy and they have four daughters and five sons. He and Joy are strong advocates for adoption. They have adopted six of their nine children. The couple also serves as foster parents, having fostered 18 children in the last four years. Cole and his wife are the founders of Love 100 Ministry, which assists Alabama families with adoption costs.

He has been an active member of Morningview Baptist Church for more than 40 years and previously served as lay elder and as chair of the deacons. In addition, he teaches a Sunday school class as a way to invest in the lives of young adults.

Cole is past president of the Jimmy Hitchcock Memorial Award, a prestigious award honoring Christian student athletes in Montgomery. He serves on the Board of Directors of Trinity Presbyterian School and the Fellowship of Christian Athletes, and is a YMCA basketball coach.

During the ceremony, Augusta S. Dowd of White Arnold & Dowd, PC, (Birmingham) was installed as the bar’s president-elect. Dowd will serve one year in this role before assuming the presidency in July 2017.

The Alabama State Bar Communications Office can be reached at 334-517-2212 or kelley.lee@alabar.org. To schedule an interview with Cole Portis, contact Helen Taylor, Public Relations Coordinator for Beasley Allen, at 334-495-1169 or Helen.Taylor@beasleyallen.com.

Free Legal Consultation
At Beasley Allen, there is never a fee for legal services, unless we collect for you. Contact us today by filling out a brief questionnaire, or by calling our toll free number, 1-800-898-2034, for a free, no-cost no-obligation evaluation of your case.

Government targets Ambulance Transport Fraud

posted on:
June 14, 2016

author:
Andrew Brashier

Last year Medicare paid more than $50 million in potentially improper bills from ambulance companies. These potential improper bills regarded ambulance rides for older Americans.

According to a report by the Inspector General, one in five ambulance services, which were billing Medicare, had some type of problematic bill. This is one in five ambulances out of nearly 16,000. Because of these numbers, the U.S. Department of Health and Human Services (HHS) announced last year that the Center for Medicare and Medicaid Services is pursuing a new strategy to combat this ambulance transport fraud. This new strategy has already been implemented and is making a difference in Pennsylvania.

Under Medicare, ambulance rides are covered when (1) other kinds of transportation would endanger the patient’s health and (2) when the patient is traveling to and from medical facilities. Ambulance transport fraud occurs when an ambulance company transports a patient who could have otherwise traveled safely to the medical facility themselves, or at least without the aid of an ambulance, and then falsifies the reports to make it appear that the patient medically needed to be transported by ambulance.

In the last couple of years, the government has been targeting ambulance transport fraud. An effective strategy, which has been implemented in Philadelphia, is new ambulance companies are not allowed to be paid by Medicare, and all repetitive nonemergency trips must receive prior authorization before the trip will be authorized by Medicare.

This strategy not only deters the fraud by requiring prior authorization, it also prohibits new companies from being developed for the sole purpose of defrauding the government. Many ambulance companies, when shut down by the government, start back up under a new name. This new rule disallows that from happening.

For example, Bassem Kuran, a driver for Brotherly Love Ambulance Inc., is to be arraigned this month for his activities with VIP Ambulance Inc., a company he started when the government closed Brotherly Love Ambulance Inc. due to Medicare fraud allegations. Kuran has allegedly been defrauding the government through ambulance transit fraud. One allegation is Kuran billed Medicare for transporting a patient for dialysis who did not even need dialysis. Transporting a single patient for dialysis for a year could equal $67,000 in revenue from billing Medicare.

According to Pennsylvania Department of Health data, 83 ambulance companies have closed since early 2014. Since this new program has been implemented in three states (Pennsylvania, New Jersey and South Carolina), the average monthly Medicare cost, in the aggregate for those three states, for scheduled, repetitive ambulance trips has plunged from $18.9 million to $5.4 million.

The qui tam provision of the False Claims Act (FCA) allows private individuals to file lawsuits on behalf of the government when those individuals have knowledge of a person or company defrauding the government. Therefore, private citizens can aide the government in stamping out ambulance transport fraud. The FCA provides monetary incentives for these private individuals, known as whistleblowers, which include 15 to 30 percent of the damages recovered.

Are you aware of fraud being committed against the federal Government, or a state Government? If so, the FCA can protect and reward you for doing the right thing by reporting the fraud. If you have any questions about whether you qualify as a whistleblower, please contact an attorney at Beasley Allen for a free and confidential evaluation of your claim. There is a contact form on this website, or you may email one of the lawyers on our whistleblower litigation team: Archie Grubb, Larry Golston, Lance Gould or Andrew Brashier.

Sources:
Philly.com
Philly.com
Washington Post
U.S. Department of Justice

Free Legal Consultation
At Beasley Allen, there is never a fee for legal services, unless we collect for you. Contact us today by filling out a brief questionnaire, or by calling our toll free number, 1-800-898-2034, for a free, no-cost no-obligation evaluation of your case.

Public advised not to drink tap water following EPA drinking water health advisory

posted on:
June 14, 2016

author:
Staff

category:
Environmental

On June 2, the West Morgan-East Lawrence Water and Sewer Authority advised the pubic served by the water system to stop drinking tap water until further notice due to the presence of potentially hazardous levels of toxic chemicals in the water. About 100,000 people are served by the water system in Lawrence and Morgan Counties, including about 10,000 direct residential customers. Consumers are advised not to drink the tap water or use it for cooking. Boiling the water or using a household water filtration system will not remove the contaminants. Beasley Allen is currently investigating and talking with representatives from multiple water systems about the developing situation.

The “stop drinking” warning follows a May 19 U.S. Environmental Protection Agency (EPA) drinking water health advisory for man-made chemicals known as PFOS and PFOA. Eight water systems in Alabama were found to have chemical levels that exceed the EPA’s standard for safety, a limit of 70 parts per trillion. The previous EPA advisory level also was based on short-term exposure. The new advisory warns of health risks connected to consuming drinking water containing the chemicals for a prolonged period, which the EPA says reflects emerging science that lower concentrations can still have long-term impacts.

“The recent ‘stop drinking’ warning from the West Morgan-East Lawrence Water and Sewer Authority further emphasizes the importance of the new EPA drinking water health advisory,” said Rhon Jones, Principal & Toxic Torts Section Head for Beasley, Allen, Crow, Methvin, Portis & Miles, P.C. “The water systems in Alabama that are impacted by the new health advisory are being placed in a difficult positon, because the PFOA/PFOS present in their systems were put there by companies that I believe have known for many years the potential harm these chemicals can cause. It is unfair to those water systems, and the thousands of people who depend on them.”

These chemicals were primarily used to manufacture non-stick cookware, stain resistant products, firefighting foam, waterproof clothing and other products. They do not break down naturally, and concentrations of these chemicals can build up in people over time.

Even before the new EPA advisory, the West Morgan-East Lawrence Water Authority filed a federal lawsuit last year against 3M, alleging the manufacturing facility in Decatur, Ala., was a major producer of both PFOS and PFOA until 2002. The lawsuit alleges negligence, public nuisance and trespass.

For more information about this issue, contact Rhon Jones, Principal and Toxic Torts Section Head, at Rhon.Jones@beasleyallen.com, or Helen Taylor, Public Relations Coordinator, at Helen.Taylor@beasleyallen.com.

Free Legal Consultation
At Beasley Allen, there is never a fee for legal services, unless we collect for you. Contact us today by filling out a brief questionnaire, or by calling our toll free number, 1-800-898-2034, for a free, no-cost no-obligation evaluation of your case.

Beasley Allen lawyers finalists for 2016 Public Justice Trial Lawyer of the Year Award

posted on:
June 9, 2016

author:
Staff

category:
Community

Beasley, Allen, Crow, Methvin, Portis & Miles, P.C., has been selected as a finalist for the 2016 Public Justice Trial Lawyer of the Year award for our work on litigation related to Johnson & Johnson talcum powder and its link to an increased risk of ovarian cancer. Nominees are Jere L. Beasley, Ted G. Meadows, David P. Dearing, Danielle Ward Mason and Brittany Scott from Beasley Allen, along with R. Allen Smith, Jr., of The Smith Law Firm from Ridgeland, Miss.; and Stephanie Rados, James G. Onder, Michael J. Quillin and W. Wylie Blair of the St. Louis firm Onder, Shelton, O’Leary & Peterson, LLC. The trial team led the litigation against Johnson & Johnson, Johnson & Johnson Consumer Companies, Inc., and Imerys Talc America, Inc.

On May 2, a jury in City of St. Louis Circuit Court found Johnson & Johnson liable for ovarian cancer linked to genital use of its talcum powder products. The jurors awarded Gloria Ristesund $55 million, which included $5 million in actual damages and $50 million in punitive damages. Earlier, in February, another jury awarded the family of Jacqueline Fox $72 million, holding Johnson & Johnson liable for her ovarian cancer death. In that verdict, $62 million was punitive damages. The purpose of awarding punitive damages is to punish a company for wrongdoing and to compel it to change its actions.

This is the second time Beasley Allen attorneys have been nominated for this award. The trial team that worked on Toyota litigation related to sudden unintended acceleration were nominated for the 2014 Public Justice Trial Lawyer of the Year Award. That trial team included Jere L. Beasley, J. Cole Portis, R. Graham Esdale, and Benjamin E. Baker of Beasley Allen; Larry Tawwater of The Tawwater Law Firm in Oklahoma City, Okla.; and Paul Martin of Martin Jean Jackson in Ponca City, Okla. This team led the charge against Toyota on behalf of the Bookout and Schwarz families. Bookout v. Toyota Motor Corp. was the first suit to go to trial against Toyota tying sudden unintended acceleration to electronic throttle control problems.

Public Justice pursues high impact lawsuits to combat social and economic injustice, protect the Earth’s sustainability, and challenge predatory corporate conduct and government abuses. Public Justice presents its Trial Lawyer of the Year Award to the attorney(s) who made the greatest contribution to the public interest within the past year by trying or settling a precedent-setting, socially significant case. The finalists will be honored and the award presented at the annual Public Justice gala at the Millennium Biltmore in Los Angeles, on July 24, 2016. A full list of the nominees and more information can be found at www.publicjustice.net.

 

Free Legal Consultation
At Beasley Allen, there is never a fee for legal services, unless we collect for you. Contact us today by filling out a brief questionnaire, or by calling our toll free number, 1-800-898-2034, for a free, no-cost no-obligation evaluation of your case.

Unnecessary inpatient admissions results in government intervention in False Claims Act lawsuit

posted on:
June 7, 2016

author:
Larry Golston

category:
Fraud

Late last month, the Department of Justice (DOJ) announced that the United States has decided to intervene in a False Claims Act (FCA) lawsuit against Prime Healthcare Services Inc. (Prime). The United States alleges that Prime improperly admitted patients into its hospitals, resulting in false claims being submitted to Medicare.

Prime allegedly pressured its Emergency Department physicians and administrators to raise inpatient admissions. This pressure forced doctors to admit patients when admission was not medically necessary.

When a person visits the emergency room, the doctor has options on how to treat them. The doctor could treat the patient as an outpatient, place the patient in observation, discharge the patient, or admit the patient. When corporations such as Prime place undue pressure on doctors to raise admission rates, doctors are forced to admit patients even if admission was not medically necessary. Under the DOJ’s theory, because these admissions were medically unnecessary, Prime submitted false claims to federal health care programs like Medicare.

When hospitals conduct practices such as these, they not only contribute to the rising cost of health care, but they also put the patient in risk. U.S. Attorney Eileen M. Decker for the Central District of California stated, “Fraudulent billing practices, such as those alleged in this civil lawsuit, harm taxpayers who fund health care programs, such as Medicare.”

As Medicare is forced to pay claims for unnecessary medical treatment, the cost of that medical treatment rises as the pool of taxpayer funds is diminished. It then falls upon the taxpayer to replenish the pool.

The Government works vigorously in its war against fraud. One of the most powerful weapons in its arsenal is the FCA, which empowers private citizens to report fraud committed against the Government. The ordinary individual becomes extraordinary as they come to be a whistleblower and file suit on behalf of the United States. The FCA permits the Government to intervene in these qui tam cases, which it has done in this case.

As a reward for doing the right thing, the whistleblower is entitled to 15 to 30 percent of whatever the government recovers for their part in the case. The DOJ has recovered more than $29 billion through the FCA since January 2009. Of that $29 billion, more than $17.5 billion was recovered in cases concerning fraud against federal health care programs.

Are you aware of fraud being committed against the federal Government, or a state Government? If so, the FCA can protect and reward you for doing the right thing by reporting the fraud. If you have any questions about whether you qualify as a whistleblower, please contact an attorney at Beasley Allen for a free and confidential evaluation of your claim. There is a contact form on this website, or you may email one of the lawyers on our whistleblower litigation team: Archie Grubb, Larry Golston, Lance Gould or Andrew Brashier.

Source: U.S. Department of Justice

Free Legal Consultation
At Beasley Allen, there is never a fee for legal services, unless we collect for you. Contact us today by filling out a brief questionnaire, or by calling our toll free number, 1-800-898-2034, for a free, no-cost no-obligation evaluation of your case.

Public Citizen documents history of Pharma fraud

posted on:
June 6, 2016

author:
Kurt Niland

category:
Fraud

The non-profit citizens’ advocacy organization Public Citizen has published a report documenting all the major financial settlements and court judgements between pharmaceutical companies and federal and state governments from 1991 through 2015.

The report provides the most complete view to date of the extent of drug company fraud and other misconduct aimed at Medicare, Medicaid, and other taxpayer-funded healthcare programs in the last quarter century.

Public Citizen found that drug makers entered into 373 settlements totaling $35.7 million in recoveries, including criminal and civil penalties for both federal and state health care programs. The organization noted that only settlements of at least $1 million for the period prior to July 19, 2012, were included in the report’s figures, indicating that the total recoveries are almost certainly higher.

Of the 373 settlements, 140 were federal settlements that recovered $31.9 billion and 233 were state settlements that resulted in returns totaling $3.8 billion.

Public Citizen emphasized a number of other key findings its research revealed:

Financial penalties declined sharply since 2013. In the most recent two-year period (2014-2015), just $2.4 billion in federal financial penalties were recovered, less than one-third of the $8.7 billion in federal penalties collected in 2012-2013 and the lowest two-year total since 2004-2005.

Public Citizen catalogued 20 state settlements totaling $424 million from 2014-2015, but 95 settlements totaling $1.2 billion from 2012-2013. That means during 2014-2015 there was an 80 percent drop in the number of state settlements over the previous two-year period.

Almost all of the decrease in the total number of settlements in 2014 and 2015 could be attributed to the sharp decrease in the number of single-state settlements involving overcharging government health programs, from a combined 73 settlements in 2012 and 2013 to just five in 2014 and 2015, a 93 percent drop.

The most common violation in the 25-year period was overcharging government health care programs. The majority of this fraud targeted state Medicaid programs. However, the unlawful, off-label promotion of drugs was the one violation that resulted in the highest penalties.

A decline in the number of federal settlements involving the unlawful promotion of drugs and medical devices accounted for the sharp decline in financial penalties in 2014-2015. Federal financial penalties from these violations declined 90 percent from about $2.8 billion in 2012-2013 to $263 million in 2014-2015.

Criminal penalties, all of which were federal during the 25-year period analyzed, dropped more than 98 percent from $2.7 billion in 2012-2013 to $44 million in 2014-2015.

Fifty-eight percent of the federal settlements (81 of 140) and 71 percent of federal penalties ($22.8 billion out of $31.9 billion) were the result of False Claims Act cases initiated by whistleblowers in the 25-year period. There were far fewer whistleblower settlements and penalties on the state level.
According to Public Citizen, just 17 of 233 (7 percent) state settlements and $793 million of $3.8 billion (21 percent) in state financial penalties originated from whistleblower cases. Of the state recoveries, Texas accounted for nine of 17 (53 percent) settlements and $409 million of $793 million (52 percent) in financial penalties.

GlaxoSmithKline and Pfizer reached the most settlements (31 each) and paid the most in financial penalties — $7.9 billion and $3.9 billion, respectively — to the federal and state governments.

Johnson & Johnson, Merck, Abbott, Eli Lilly, Teva, Schering-Plough, Novartis, and AstraZeneca also paid more than $1 billion in financial penalties. Thirty-one companies entered into repeat settlements with the federal government during the period analyzed, with Pfizer (11), Merck (9), GlaxoSmithKline, Novartis, and Bristol-Myers Squibb (8 each) finalizing the most federal settlements.

Source: Public Citizen

Free Legal Consultation
At Beasley Allen, there is never a fee for legal services, unless we collect for you. Contact us today by filling out a brief questionnaire, or by calling our toll free number, 1-800-898-2034, for a free, no-cost no-obligation evaluation of your case.

Mississippi Supreme Court upholds $30 million judgment against Sandoz in AWP litigation

posted on:
June 1, 2016

author:
Staff

category:
Fraud

Our firm has been serving as Special Counsel to Mississippi Attorney General Jim Hood for several years on the Average Wholesale Price (AWP) litigation and have recovered from 61 companies for the State of Mississippi more than $200 million to date, including a $30 million verdict against generic pharmaceutical giant Sandoz, Inc., back in 2011.

That verdict was appealed by Sandoz, Inc., and the Mississippi Supreme Court affirmed the verdict in full last October. Sandoz, Inc., asked the Mississippi Supreme Court to rehear the appeal last November, but on May 26, 2016, the court denied Sandoz’s rehearing request, effectively exhausting their last chance at an appeal.

General Hood applauded the Mississippi Supreme Court’s refusal to reconsider its October 2015 decision that affirmed the state’s $30 million verdict. “It is reassuring to know that when a big drug company like Sandoz cheats the taxpayers, justice will prevail,” Attorney General Hood said. “The court made the right decision to turn back a greedy corporation that focused on its own profits at the expense of the people of Mississippi.”

This case came to the Mississippi Supreme Court following a nine-day bench trial in Rankin County Chancery Court. Chancellor Tom Zebert concluded that Sandoz defrauded Mississippi, and cost taxpayers $24 million when it reported Average Wholesale Prices, or AWPs, that grossly exceeded the actual prices Sandoz charged its customers.

Those manipulated prices caused the state to pay more for prescription drugs for Medicaid recipients. As a result of this fraud, the trial court awarded the state compensatory, statutory, and punitive damages.

The case against Sandoz was among dozens of similar cases brought against other drug companies that also manipulated their reported AWPs so that Mississippi paid too much for prescription drugs for Medicaid recipients.

Our firm represented eight states in this same litigation and recovered more than $1.5 billion in settlements and jury verdicts for the states. The AWP trial team was led by Dee Miles with Roman Shaul, Clay Barnett, Ali Hawthorne and Chad Stewart (1972-2014) assisting.

Free Legal Consultation
At Beasley Allen, there is never a fee for legal services, unless we collect for you. Contact us today by filling out a brief questionnaire, or by calling our toll free number, 1-800-898-2034, for a free, no-cost no-obligation evaluation of your case.

New York based bank pays $64 million to settle False Claims Act allegations concerning Insured Mortgage Lending

posted on:
May 31, 2016

author:
Lance Gould

The Department of Justice (DOJ) announced earlier this month that M&T Bank Corp. (M&T Bank), a bank headquartered in New York, has agreed to settle False Claims Act (FCA) allegations for $64 million. These allegations concern M&T Bank’s lending practices and claim M&T Bank was knowingly originating and underwriting loans that did not meet certain requirements to be insured by the Federal Housing Administration (FHA).

Some banks have the option to participate as a direct endorsement lender (DEL). DELs are able to underwrite, originate, and endorse mortgages for FHA insurance. If a person defaults on one of these mortgages, the holder of the loan (the bank) may submit an insurance claim to the Department of Housing and Urban Development (HUD), which is the parent agency for the FHA. The problem is, under this program, these loans are not reviewed by the FHA before they are endorsed for FHA insurance.

Therefore, there are strict requirements the loans must meet before a DEL can certify the mortgages for FHA insurance. Moreover, the DEL must maintain a quality control program and report any deficient loans identified by that program.

Principle Deputy Assistant Attorney General Benjamin C. Mizer, head of the Justice Department’s Civil Division, stated, “Mortgage lenders that fail to follow FHA program rules put taxpayer funds at risk and increase the chances of borrowers losing their homes.”

In this case, the allegations were M&T Bank failed to comply with the requirements set forth by the FHA. In addition, it was alleged that M&T Bank created a quality control system that detected significantly lower major error rates. Moreover, even though M&T Bank did detect numerous loans with major errors, the bank failed to report these loans to HUD. Therefore, HUD insured hundreds of loans that were not qualified for the FHA insurance.

The FCA contains a qui tam provision, which allows private citizens to sue on behalf of the government when they have knowledge of an entity committing fraud against the government. The qui tam provision provides incentives for ordinary citizens to become whistleblowers by reporting the fraud. These incentives include 15 to 30 percent of the monies recovered and protection against retaliation.

This case was originally filed under the qui tam provision of the FCA by a former employee of M&T Bank. Though the share to be awarded to the whistleblower has not yet been determined, the employee stands to receive anywhere from $9.5 million to $19 million as an award for her participation in the case.

Are you aware of fraud being committed against the federal government, or a state government? If so, the FCA can protect and reward you for doing the right thing by reporting the fraud.

If you have any questions about whether you qualify as a whistleblower, please contact an attorney at Beasley Allen for a free and confidential evaluation of your claim. There is a contact form on this website, or you may email one of the lawyers on our whistleblower litigation team: Archie Grubb, Larry Golston, Lance Gould or Andrew Brashier.

Source: U.S. Department of Justice

Free Legal Consultation
At Beasley Allen, there is never a fee for legal services, unless we collect for you. Contact us today by filling out a brief questionnaire, or by calling our toll free number, 1-800-898-2034, for a free, no-cost no-obligation evaluation of your case.

Lawsuits target drug makers over testosterone side effects

posted on:
May 31, 2016

author:
Staff

Testosterone drugs heavily advertised by pharmaceutical companies for men who have “Low T,” or low testosterone, to fight symptoms that come naturally as a man ages, have been linked to serious heart risks and are among the top Dangerous Drug & Medical Device Lawsuits cited by the Drug Lawsuit Source.

“Recent medical and scientific studies have shown that there are several serious health risks to men caused by these drugs,” the website warns. “In fact, recent studies have identified a link between testosterone replacement therapy and increased risk of heart attacks. Other side effects of the drugs include non-fatal myocardial infarction, strokes, blood clots, enlarged breasts and mood swings. As a result of these conditions, death can occur.”

Testosterone replacement therapies are available in patches, topical solutions, topical gels, tablets, injections and pellets. Brand names include Androgel, Axiron, Bio-T-Gel, Delatestryl, Depo-Testosterone, Fortesta, Striant, Testim and Testopel. These prescription drugs are intended to increase testosterone levels in men with hypogonadism, a condition in which men do not produce enough of the hormone due to disease or injury, resulting in symptoms such as low libido, muscle loss, and fertility issues.

Testosterone levels naturally decrease as a man ages. Drug companies have aggressively advertised testosterone as a treatment for older men with low testosterone levels. However, studies show that boosting testosterone levels in men with age-related hypogonadism may expose them to serious health risks such as heart attacks, strokes and death.

Manufacturers of testosterone replacement products are facing a growing number of lawsuits alleging the companies did not adequately warn doctors or the public of the potential heart risks associated with testosterone treatment.

Source: Drug Lawsuit Source

Free Legal Consultation
At Beasley Allen, there is never a fee for legal services, unless we collect for you. Contact us today by filling out a brief questionnaire, or by calling our toll free number, 1-800-898-2034, for a free, no-cost no-obligation evaluation of your case.
back to top